A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 33, Issue 11, 2006, Pages 1589-1593

  Nishio, Shin ^a   Katsumata, Noriyuki ^a   Tanabe, Hiroshi ^a   Matsumoto, Koji ^a   Yonemori, Kan ^a   Kouno, Tsutomu ^a   Shimizu, Chikako ^a   Ando, Masashi ^a   Fujiwara, Yasuhiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AP PROTOCOL 1; CISPLATIN; DOXORUBICIN;

ADENOCARCINOMA; ADULT; AGED; ANEMIA; ARTICLE; CANCER STAGING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; ENDOMETRIUM TUMOR; FEASIBILITY STUDY; FEMALE; HUMAN; MIDDLE AGED; NEUTROPENIA; PATHOLOGY; POSTOPERATIVE PERIOD; VOMITING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; POSTOPERATIVE PERIOD; VOMITING, ANTICIPATORY;

EID: 34748821460     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)